Science Explorer Back to mapMap
Discussion
Company · Exton · United States

Morphotek (United States)

Research works
66
▼ 100% vs 2018-21
Citations
2k
30.2 per fractional work
Top-10% rate
21.1%
all institutions 10.0%
Open access
43%
world 40%
International
12%
world 18%

Not ranked overall: Morphotek (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Morphotek (United States) work in?

In all years, 56% of research at Morphotek (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (8%). It does 2.4× the world's share of Life Sciences.

Health Sciences: 37 fractional works · 56.0% of its workMedicine: 37 fractional works · 56.0% of its workOncology: 11 fractional works · 17.1% of its workRadiology, Nuclear Medicine and Imaging: 9 fractional works · 13.6% of its workPulmonary and Respiratory Medicine: 5 fractional works · 7.3% of its workRheumatology: 3 fractional works · 4.4% of its workReproductive Medicine: 2 fractional works · 2.8% of its workImmunology and Allergy: 1 fractional works · 1.6% of its workPathology and Forensic Medicine: 1 fractional works · 1.6% of its workSurgery: 1 fractional works · 1.2% of its workNephrology: 1 fractional works · 1.0% of its workEpidemiology: 1 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workHematology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workLife Sciences: 28 fractional works · 41.6% of its workBiochemistry, Genetics and Molecular Biology: 20 fractional works · 30.8% of its workMolecular Biology: 11 fractional works · 17.0% of its workBiotechnology: 5 fractional works · 7.7% of its workCancer Research: 3 fractional works · 5.2% of its workGenetics: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 6 fractional works · 8.4% of its workImmunology: 5 fractional works · 7.9% of its workMicrobiology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 1.0% of its workFood Science: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 2.4% of its workChemistry: 1 fractional works · 1.0% of its workOrganic Chemistry: 1 fractional works · 1.0% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workALL ITS WORKMorphotek (UnitedStates)66fractional works, all years
Life Sciences42%Physical Sciences2%Health Sciences56%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Medicine3756.0%
    1. Biochemistry, Genetics and Molecular Biology2030.8%
    2. Immunology and Microbiology68.4%
    3. Agricultural and Biological Sciences11.0%
    4. Pharmacology, Toxicology and Pharmaceutics00.8%
    5. Neuroscience00.7%
    1. Chemistry11.0%
    2. Engineering00.8%
    3. Materials Science00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Morphotek (United States)?

    Ranked on the quality score, Daniel John O'Shannessy, Nicholas C. Nicolaides and Philip M. Sass lead among researchers whose main affiliation is Morphotek (United States).

    1. 1 Daniel John O'Shannessy United States · #178,904 worldwide 5.7k citations · 106 works
    2. 2 Nicholas C. Nicolaides United States · #206,173 worldwide 17k citations · 169 works
    3. 3 Philip M. Sass United States · #593,126 worldwide 3.5k citations · 41 works
    4. 4 Martin D. Phillips United States · #825,027 worldwide 1.3k citations · 21 works
    5. 5 Elizabeth Brooke Somers United States · #1,053,487 worldwide 1.7k citations · 39 works
    6. 6 Qimin Chao United States · #1,192,531 worldwide 4.1k citations · 18 works
    7. 7 Luigi Grasso United States · #1,275,531 worldwide 2.8k citations · 122 works
    8. 8 Susan C. Weil United States · #1,374,582 worldwide 1.9k citations · 61 works
    9. 9 Wolfgang Ebel United States · #1,581,623 worldwide 894 citations · 18 works
    10. 10 Charles Schweizer United States · #1,597,315 worldwide 925 citations · 30 works
    All ranked researchers at Morphotek (United States)

    What are the most cited papers from Morphotek (United States)?

    The most cited paper from Morphotek (United States) is "Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance" (Daniel John O'Shannessy, Gordon H. Yu, Robert Smale et al., 2012), with 242 citations. Next come "Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers" (203) and "Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin." (189).

    Most cited papers
    #PaperReleasedCitations
    1 Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance Daniel John O'Shannessy, Gordon H. Yu, Robert Smale et al. · Oncotarget Open access 29 Apr 2012 242
    2 Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers Raffit Hassan, Steven J. Cohen, Martin D. Phillips et al. · Clinical Cancer Research Open access 29 Oct 2010 203
    3 Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Raffit Hassan, Wolfgang Ebel, Eric Routhier et al. · PubMed Open access 19 Dec 2007 189
    4 Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma Raffit Hassan, Hedy Lee Kindler, Thierry Marie Jahan et al. · Clinical Cancer Research Open access 18 Sep 2014 184
    5 Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease Daniel John O'Shannessy, Elizabeth Brooke Somers, Julia D. Maltzman et al. · SpringerPlus Open access 28 Sep 2012 158
    All 89 most cited papers, with filters and sorting

    Which keywords describe research at Morphotek (United States)?

    By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cancer, Antibody Engineering, Fc Receptors, Immunotherapy and Angiogenesis.

    ▲ more of its work than of the world's◆ about the world's share▼ less than the world's

    Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

    All 40 words, with their numbers
    1. Glycosylation10▲ 72×3 topics
    2. Monoclonal Antibodies9▲ 95×3 topics
    3. Therapeutic Antibodies8▲ 101×2 topics
    4. Antibody Engineering8▲ 113×1 topic
    5. Cancer8▲ 8.1×13 topics
    6. Fc Receptors8▲ 113×1 topic
    7. Immunotherapy7▲ 16×7 topics
    8. Angiogenesis6▲ 24×7 topics
    9. Chemotherapy6▲ 13×7 topics
    10. Breast Cancer5▲ 27×5 topics
    11. Tumor Regression5▲ 86×2 topics
    12. Inflammation5▲ 3.1×12 topics
    13. Monoclonal Antibody5▲ 99×2 topics
    14. Tumor Targeting5▲ 53×3 topics
    15. Gene Therapy4▲ 25×2 topics
    16. Cancer Therapy4▲ 10×8 topics
    17. Metastasis4▲ 19×6 topics
    18. Arginine Deprivation4▲ 141×1 topic
    19. Bacterial Therapy4▲ 141×1 topic
    20. HER24▲ 182×1 topic
    21. Trastuzumab4▲ 129×1 topic
    22. Targeted Therapy3▲ 24×3 topics
    23. Tumor Suppression3▲ 45×2 topics
    24. Clinical Trials3▲ 7.4×3 topics
    25. Autoimmunity3▲ 20×2 topics
    26. Endothelial Dysfunction3▲ 15×2 topics
    27. Regulation3▲ 6.9×3 topics
    28. Folate3▲ 100×1 topic
    29. Homocysteine3▲ 100×1 topic
    30. Apoptosis2▲ 9.7×3 topics
    31. Biopharmaceuticals2▲ 56×3 topics
    32. Fibrosis2▲ 19×2 topics
    33. PET Imaging2▲ 17×4 topics
    34. Tumor Microenvironment2▲ 10×7 topics
    35. Cell Cycle2▲ 60×1 topic
    36. Cytoreductive Surgery2▲ 52×2 topics
    37. Immune Regulation2▲ 27×2 topics
    38. Immune System2▲ 11×2 topics
    39. Therapeutics2▲ 24×2 topics
    40. p532▲ 80×1 topic

    Which research topics does Morphotek (United States) publish most on?

    By volume: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, HER2/EGFR in Cancer Research and Folate and B Vitamins Research.

    1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 8 works
    2. 2 Cancer Research and Treatments Biotechnology 4 works
    3. 3 HER2/EGFR in Cancer Research Oncology 4 works
    4. 4 Folate and B Vitamins Research Rheumatology 3 works
    5. 5 Cancer-related Molecular Pathways Oncology 2 works
    6. 6 Galectins and Cancer Biology Immunology 2 works
    7. 7 Glycosylation and Glycoproteins Research Molecular Biology 2 works
    8. 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
    9. 9 Cancer Cells and Metastasis Oncology 2 works
    10. 10 Angiogenesis and VEGF in Cancer Molecular Biology 2 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available42.8%not open57.2%

    World: 40% of research is openly available.

    with international co-authors11.5%domestic only88.5%

    World: 18% is written across borders.

    How has Morphotek (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    200520102015
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Morphotek (United States) as a percentage of every work published that year, 0.00017% in 2018.

    0.00010%0.00020%0.00030%Morphotek (United States)0.000028% in 20192010

    Fractional works of Morphotek (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Exton

    All research institutions in Exton

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Morphotek (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.